Total Holdings
60
As of Oct 4, 2026
iShares Health Innovation Active ETF
BMEDNYSEARCABlackRockEquity
$34.55Today:- (-)1Y +25.23%
As of Oct 16, 2026 close
- Assets (AUM)
- $13.51M
- Expense ratio
- 0.55%
- Dividend yield
- 0.23%
- Holdings
- 60
- 52-week range
- $27.25$34.98
- Volume (live)
- -
- Avg. volume (3M)
- 2.11K
BMED ETF Holdings: iShares Health Innovation Active ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
45.2%
Share of fund assets
Assets (AUM)
$13.51M
Total fund assets
Expense Ratio
0.55%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 48 of 60 BMED Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 48 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Gilead Sciences, Inc | Stock | 5.08% |
| 2 |  | Danaher Corporation | Stock | 5.07% |
| 3 |  | Merck & Co., Inc | Stock | 4.96% |
| 4 |  | Moderna, Inc. | Stock | 4.86% |
| 5 |  | AbbVie Inc | Stock | 4.79% |
| 6 |  | Thermo Fisher Scientific Inc. | Stock | 4.36% |
| 7 |  | Johnson & Johnson | Stock | 4.36% |
| 8 |  | Charles River Laboratories International, Inc | Stock | 4.08% |
| 9 |  | IQVIA Holdings Inc | Stock | 3.85% |
| 10 |  | Edwards Lifesciences Corporation | Stock | 3.79% |
| 11 |  | Waters Corporation | Stock | 3.62% |
| 12 |  | Biogen Inc. | Stock | 3.55% |
| 13 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.46% |
| 14 |  | Mettler-Toledo International Inc. | Stock | 3.33% |
| 15 | SWX:ROP | Roche Holding AG | Stock | 2.84% |
| 16 |  | Illumina, Inc. | Stock | 2.68% |
| 17 |  | DexCom, Inc. | Stock | 2.48% |
| 18 |  | Incyte Corporation | Stock | 2.42% |
| 19 |  | Amgen Inc. | Stock | 2.42% |
| 20 | XTSLA | BLK CSH FND TREASURY SL AGENCY | Stock | 2.15% |
| 21 |  | argenx NV ADR | Stock | 2.07% |
| 22 |  | Halozyme Therapeutics, Inc | Stock | 2.06% |
| 23 | SWX:NOVN | Novartis AG | Stock | 1.85% |
| 24 |  | Genmab A/S | Stock | 1.85% |
| 25 |  | Roivant Sciences Ltd | Stock | 1.60% |
| 26 |  | Cytokinetics, Incorporated | Stock | 1.58% |
| 27 |  | Pfizer Inc | Stock | 1.54% |
| 28 | HKG:2269 | WuXi Biologics (Cayman) Inc. | Stock | 1.53% |
| 29 |  | Neurocrine Biosciences, Inc | Stock | 1.51% |
| 30 |  | Bristol-Myers Squibb Company | Stock | 1.48% |
| 31 |  | Guardant Health, Inc | Stock | 1.47% |
| 32 |  | Abbott Laboratories | Stock | 1.36% |
| 33 | SWX:GALD | Galderma Group N | Stock | 1.28% |
| 34 |  | BioMarin Pharmaceutical Inc | Stock | 1.27% |
| 35 |  | Revolution Medicines, Inc | Stock | 1.24% |
| 36 |  | Tempus AI, Inc. Class A Common Stock | Stock | 1.24% |
| 37 |  | Axsome Therapeutics, Inc | Stock | 1.18% |
| 38 |  | Protagonist Therapeutics Inc | Stock | 0.96% |
| 39 |  | Bruker Corporation | Stock | 0.81% |
| 40 | EBR:UCB | UCB SA | Stock | 0.68% |
| 41 |  | Alkermes plc | Stock | 0.66% |
| 42 |  | Dianthus Therapeutics Inc. | Stock | 0.59% |
| 43 |  | MBX | Stock | 0.49% |
| 44 |  | Erasca Inc | Stock | 0.32% |
| 45 |  | Sagimet Biosciences Inc. | Stock | 0.15% |
| 46 |  | Avalo Therapeutics Inc | Stock | 0.11% |
| 47 |  | Eikon Therapeutics, Inc. Common Stock | Stock | 0.10% |
| 48 |  | Summit Therapeutics PLC | Stock | 0.10% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About iShares Health Innovation Active ETF Holdings
What are the top holdings in BMED?
As of Oct 4, 2026, iShares Health Innovation Active ETF (BMED) holds 60 securities. The largest are Gilead Sciences, Inc (5.08%), Danaher Corporation (5.07%), Merck & Co., Inc (4.96%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is BMED's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 45.2% of BMED's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is BMED's sector allocation?
The Sector Allocation chart shows how BMED distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BMED invest in?
BMED's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BMED ETF?
BMED's diversification can be assessed by reviewing its 60 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.